MYD88 and metabolic dysfunction-associated steatohepatitis: Reduce the infiltration of macrophages, especially the infiltration of pro-inflammatory M1, and inhibite the pathways of TLR4, Myeloid differentiation primary response gene 88 (MyD88) to prevent MASH.